Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Covington Advises ReNeuron Group plc on £68.4 million Follow-on Financing

July 13, 2015

LONDON, 13 July, 2015 — Covington is advising AIM-listed ReNeuron Group plc, a leading clinical stage stem cell therapy company, on its latest follow-on financing announced on 10 July. ReNeuron is raising £68.4 million by way of an institutional placing of new shares arranged by Cenkos Securities plc. The placing is conditional on the receipt of certain shareholder approvals and is expected to close in August 2015.

The fundraising will enable the company to build on the recent progress achieved across its therapeutic programs.

The team comprised of partners Paul Claydon and Kristian Wiggert, and associates Kristian Shearsby and Sarah HoultGuy Dingley and Rob Heller provided tax advice.

Share this article: